2026 年至 2032 年妇科设备市场（按产品、最终用户和地区）

妇科设备市场评估-2026-2032

3D内视镜等先进影像工具的开发，以及有助于提高微创手术效果的妇科设备的改进，预计将推动该产业的发展。内视镜检查、腹腔镜检查、切除术和女性节育手术等外科手术数量的增加，预计将增加对这些产品的需求，预计到2023年，这些产品的价值将超过143.5亿美元，到2032年将达到约325.2亿美元。

除此之外，妇科疾病发生率的上升也有望在整个预测期内刺激市场扩张。此外，尖端和新技术的广泛使用也有望推动产业扩张，使利基市场在2026年至2032年期间的复合年增长率达到10.77%。

全球妇科设备市场定义/概述

用于与女性生殖相关的外科手术、治疗和诊断程序的各种医疗器械和设备被称为妇科器械。妇科器械用于女性保健的各个方面。它们在妇科检查中至关重要，有助于发现和诊断子宫内膜异位症、骨盆腔发炎和子宫颈癌等疾病。

妇科设备在各种妇科疾病的诊断、治疗和监测中至关重要。它用于识别生殖器官异常、进行微创手术和实施避孕措施。例如，超音波扫描用于检测卵巢囊肿和子宫肌瘤，而腹腔镜检查用于治疗子宫内膜异位症和切除子宫肌瘤。

机器人辅助手术精度更高、恢復时间更短，预计将越来越受欢迎。数位影像技术将持续改进，从而实现更早的诊断和更准确的病情评估。此外，人工智慧 (AI) 与机器学习 (ML) 的融合有望透过提供个人化治疗提案和改善患者预后，彻底改变妇科护理。

全球妇科疾病的增加如何推动全球妇科设备市场的成长？

妇科疾病的发生率不断上升，以及人们对女性健康问题的认识不断提高，推动着全球妇科设备市场的发展。随着越来越多的女性寻求早期诊断和治疗，该领域对先进医疗设备的需求也日益增长。根据世界卫生组织 (WHO) 的数据，截至 2024 年 3 月，子宫颈癌仍是全球女性第四大常见癌症，预计 2023 年新增病例将达 60.4 万例。这凸显了改善筛检和治疗技术的需求。

微创手术和诊断工具的技术进步正在扩展妇科设备的功能。对于医疗保健提供者而言，这些创新转化为改善患者预后、缩短復原时间并提高手术效率。 2024年2月，美国食品药物管理局）报告称，新妇科设备的核准与前一年同期比较增加了22%。

女性人口老化以及由此导致的与老龄化相关的妇科疾病的增多，正在推动市场成长。随着预期寿命的延长，对治疗骨盆器官脱垂和尿失禁等问题的器械的需求也随之增长。美国人口普查局预测，到2030年，所有婴儿潮世代都将达到或超过65岁，这将扩大最有可能需要妇科干预的人群范围。

严格的政府规章制度将如何阻碍全球妇科设备市场的成长？

监管障碍和严格的核准流程对全球妇科器械市场构成了重大挑战。製造商必须透过复杂且通常冗长的监管途径将新器械推向市场，这可能会减缓创新并增加成本。根据美国食品药物管理局，截至 2024 年 6 月，妇科器材 510(k) 核准的平均时间为 177 天，与前一年同期比较增加了 15%。

新兴国家医疗保健和妇科服务可近性有限，阻碍了其发展。许多中低收入国家的女性在获得充足的妇科护理方面面临障碍，包括缺乏训练有素的医疗保健人员和充足的医疗基础设施。世界卫生组织（WHO）于2024年3月报告称，开发中国家只有62%的女性能够接受定期妇科检查。

对某些妇科器材安全性和有效性的担忧，导致审查力道加大，市场也因此犹豫不决。过去围绕着经阴道网片植入物等器械的争议，提高了患者和医疗保健提供者的认知度，影响了新技术的采用率。美国政府问责局 (美国 Government 课责 Office) 于 2024 年 2 月报告称，过去两年，与妇科器械相关的不利事件报告增加了 22%。

目录

第一章全球妇科器械市场介绍

• 概述
• 研究范围
• 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

• 资料探勘
• 验证
• 第一手资料
• 资料来源列表

第四章 妇科器材全球市场展望

• 概述
• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 波特五力模型
• 价值链分析

第五章全球妇科设备市场（按产品）

• 概述
• 手术设备
  • 妇科内视镜设备
  • 内视镜成像系统
  • 流体管理系统
  • 女性避孕/避孕装置
• 手持式仪器
  • 窥器
  • 持钩
  • 奎莱特
  • 特罗克市场
  • 切片检查
  • 其他的
• 诊断影像系统

6. 全球妇科设备市场（依最终用户）

• 概述
• 医院和诊所
• 门诊手术中心（ASC）

7. 全球妇科设备市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 其他的
  • 拉丁美洲
  • 中东和非洲

第八章全球妇科设备市场竞争格局

• 概述
• 各公司市场排名
• 重点发展策略

第九章 公司简介

• Medtronic plc
• Cooper Surgical, Inc.
• Richard Wolf GmbH
• Hologic, Inc.
• Boston Scientific Corp.
• Stryker Corp.
• Karl Storz GmbH & Co. KG
• Ethicon, Inc.（Johnson & Johnson MedTech）
• Cook Medical
• Bayer AG

第十章 附录

• 相关调查

Gynecological Devices Market Valuation - 2026-2032

The development of sophisticated imaging tools like 3D endoscopes and improvements in gynaecological equipment that help to increase the effectiveness of minimally invasive surgical techniques are anticipated to propel the growth of the industry. The demand for the product is anticipated to rise due to the rising number of surgical operations, including endoscopy, laparoscopy, ablation, and female sterilization, surpassing USD 14.35 Billion valued in 2023 to reach a valuation of around USD 32.52 Billion by 2032.

In addition to this, the rising incidence of gynaecological problems is anticipated to fuel market expansion throughout the projected period. The increasing use of cutting-edge and novel technology is also anticipated to fuel industrial expansion, thus enabling the niche market grow at a CAGR of 10.77% from 2026 to 2032.

Global Gynecological Devices Market: Definition/ Overview

A wide range of medical tools and equipment used for surgical, therapeutic, and diagnostic procedures pertaining to women's reproductive health are referred to as gynecology devices. Gynecological devices are used in many aspects of women healthcare. They are crucial in gynecological exams, aiding in the detection and diagnosis of diseases such as endometriosis, pelvic inflammatory disease, and cervical cancer.

Gynaecology devices are indispensable in the diagnosis, treatment, and monitoring of various gynaecological conditions. They are used to identify abnormalities in the reproductive organs, perform minimally invasive surgeries, and provide contraception. For instance, ultrasound is employed to detect ovarian cysts and uterine fibroids, while laparoscopy is used to treat endometriosis and remove uterine fibroids.

Robotic-assisted surgery is expected to become increasingly prevalent, offering greater precision and reducing recovery time. Digital imaging techniques will continue to improve, enabling earlier diagnosis and more accurate assessment of conditions. Moreover, the integration of artificial intelligence (AI) and machine learning (ML) has the potential to revolutionize the gynecological care by providing personalized treatment recommendations and improving patient outcomes.

How the Rising Cases of Gynecological Disorders Worldwide Boosting the Growth of Global Gynecological Devices Market?

The increasing prevalence of gynecological disorders and the growing awareness of female health issues are driving the global Gynecological Devices Market. As more women seek early diagnosis and treatment, the demand for advanced medical devices in this field continues to rise. According to the World Health Organization, as of March 2024, cervical cancer remains the fourth most common cancer among women globally, with an estimated 604,000 new cases in 2023. This underscores the need for improved screening and treatment technologies.

Technological advancements in minimally invasive procedures and diagnostic tools are expanding the capabilities of gynecological devices. These innovations offer improved patient outcomes, reduced recovery times, and increased procedural efficiency for healthcare providers. The U.S. Food and Drug Administration reported in February 2024 that approvals for novel gynecological devices increased by 22% compared to the previous year.

The aging female population and the subsequent increase in age-related gynecological conditions are fueling market growth. As life expectancy increases, there is a greater need for devices that address issues such as pelvic organ prolapse and urinary incontinence. The U.S. Census Bureau projects that by 2030, all baby boomers will be older than 65, expanding the demographic most likely to require gynecological interventions.

How the Stringent Government Rules and Regulations Hampering the Global Gynecological Devices Market Growth?

Regulatory hurdles and stringent approval processes pose significant challenges for the global Gynecological Devices Market. Manufacturers must navigate complex and often lengthy regulatory pathways to bring new devices to market, which can delay innovation and increase costs. According to the U.S. Food and Drug Administration, as of June 2024, the average time for 510(k) clearance for gynecological devices was 177 days, a 15% increase from the previous year.

Limited access to healthcare and gynecological services in developing regions hinders market growth. Many women in low- and middle-income countries face barriers to receiving proper gynecological care, including a lack of trained healthcare providers and adequate medical infrastructure. The World Health Organization reported in March 2024 that only 62% of women in developing countries have access to regular gynecological screenings.

Concerns over the safety and efficacy of certain gynecological devices have led to increased scrutiny and potential market hesitation. Past controversies surrounding devices like transvaginal mesh implants have resulted in heightened awareness among patients and healthcare providers, impacting adoption rates of new technologies. The U.S. Government Accountability Office reported in February 2024 that adverse event reports related to gynecological devices increased by 22% over the past two years.

Category-Wise Acumens

What are the Features Bolstering the Growth of Surgical Devices Segment?

The surgical devices are emerging as a dominating segment in the global gynecology devices market, driven by technological advancements and an increasing prevalence of gynecological disorders. According to a recent report by the World Health Organization (WHO) published in March 2024, approximately 35% of women worldwide will undergo a gynecological surgical procedure in their lifetime, underscoring the critical role of these devices in women's healthcare.

Market leaders in the gynecology devices sector continue to innovate and expand their product offerings to meet growing demand. For instance, on September 15, 2024, Medtronic, a key player in the market, announced the launch of its next-generation robotic-assisted surgical system specifically designed for gynecological procedures. This cutting-edge technology promises to enhance precision and outcomes in complex surgeries, further solidifying the position of surgical devices segment at the forefront of the Global Gynecology Devices Market.

How will the Adoption of Advanced Technologies by Hospitals & Clinics Projects the Market Growth?

The hospitals & clinics segment is estimated to dominate the global Gynecological Devices Market growth during the forecast period. The rising need for gynaecological procedures and the use of cutting-edge technologies in clinics and hospitals are the primary causes of the high share. For instance, on January 2022, The Women's Hospital at Jackson Memorial, HCA Florida Healthcare's Kendall Regional Medical Center, and AdventHealth Celebration began utilizing Memic Innovative Surgery's Hominis Surgical System, a robotic surgical device, for gynaecological procedure.

The needs of women healthcare have grown as their lives have changed. With women becoming more conscious of their health and wellbeing, there has been a growing need for improved gynecological therapies. Acknowledging this potential, global medical device manufacturers have developed innovative gynecology gadgets that are painless and effective, enabling patients to heal quickly.

North America Region?

The North America is emerging as the dominating region in the global Gynecological Devices Market. Due to the rising incidence of cancer linked to gynecology, the prominence of device makers, and improvements in technology, the North American area currently owns the greatest proportion of the global market for gynecological devices. An expected 65,950 new instances of uterine corpus cancer were detected in the US in 2022, according to the American Cancer Society. Cervical cancer is the most concerning of all the cancers, and its incidence in American women is rising quickly. In the US, 14,100 cases of cervical cancer are anticipated in 2022.

In addition to this, an update from the Canadian Cancer Society in 2022 projects that 8,100 Canadian women would likely receive a uterine cancer diagnosis in 2022. As a result, the need for gynecological equipment in the nation is increasing due to the increased prevalence of cancer. Moreover, the nationwide presence of rivals, mergers, and acquisitions pertaining to gynaecological devices accelerates market expansion. For instance, in October 2021, Hologic, Inc., signed a final agreement to purchase Bolder Surgical, for about USD 160 million, subject to working capital and other customary closing adjustments.

How will the Increasing Awareness of Women's Health Issues Supports the Market Growth in the Asia-Pacific (APAC)?

The Asia-Pacific (APAC) region is estimated to grow at a highest CAGR during the forecast period, driven by increasing awareness of women's health issues, improving healthcare infrastructure, and rising disposable incomes. According to a recent report by the World Health Organization (WHO) published on March 15, 2024, the prevalence of gynecological disorders in the APAC region has increased by 12% over the past five years, highlighting the urgent need for advanced medical devices.

Key players in the gynecology devices market are actively pursuing opportunities in the APAC region through strategic partnerships and product launches. For instance, on September 12, 2023, Medtronic, a leading medical technology company, announced the establishment of a new research and development center in Singapore, focusing on innovative gynecological devices tailored to the specific needs of Asian women.

Competitive Landscape

The global Gynecological Devices Market is a dynamic and competitive landscape, with a mix of established players and emerging challengers vying for market share. These players are actively working to strengthen their presence by implementing strategic plans such as collaborations, mergers, acquisitions, and political support. The organizations are dedicated to continuously improving their product line to meet the needs of a wide range of customers in different regions.

Some of the key players operating in the global Gynecological Devices Market include:

Medtronic plc, Cooper Surgical, Inc., Richard Wolf GmbH, Hologic, Inc., Boston Scientific Corp., Stryker Corp., Karl Storz GmbH & Co. KG, Ethicon, Inc. (Johnson & Johnson MedTech), Cook Medical, Bayer AG, Gynemed, Gynex Corp.

Latest Developments

In September 2022, The Guardenia Contained Extraction System was introduced by Olympus, a leading worldwide technology company that designs and provides cutting-edge solutions for medical and surgical procedures.

In June 2022, the new Hystero-V, a single-use hysteroscope was introduced by UroViu Corp. With its hydrophilic covering, the 12-Fr semi-rigid Hystero-V allows for a smooth insertion and enhanced visualization for incredibly successful intrauterine exams.

On July 2021, the Hugo Robotic-Assisted Surgery (RAS) system, developed by Medtronic Plc, was utilized to execute the first gynaecological treatment in Panama.

Gynecological Devices Market, By Category

• Product:
• Surgical Devices
• Gynecological Endoscopy Devices
• Hysteroscope
• Colposcope
• Resectoscope
• Laparoscope
• Endoscopic imaging systems
• Endometrial Ablation Devices
• Hydrothermal Ablation Devices
• Radiofrequency Ablation Devices
• Balloon Ablation Devices
• Others (Microwave, Laser)
• Fluid Management Systems
• Female Sterilization/Contraceptive Devices
• Permanent Birth Control
• Intra Uterine Devices (IUD)
• Intravaginal rings
• Subdermal Contraceptive Implants
• Handheld Instruments
• Vaginal Speculum
• Tenaculum
• Curettes
• Trocars Market
• Biopsy Forceps
• Others
• Diagnostic Imaging Systems
• End-User:
• Hospital & Clinics
• Ambulatory Surgery Centers (ASCs)
• Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL GYNECOLOGICAL DEVICES MARKET

• 1.1 Overview
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL GYNECOLOGICAL DEVICES MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL GYNECOLOGICAL DEVICES MARKET, BY PRODUCT

• 5.1 Overview
• 5.2 Surgical Devices
  • 5.2.1 Gynecological Endoscopy Devices
  • 5.2.1.1 Hysteroscope
  • 5.2.1.2 Colposcope
  • 5.2.1.3 Resectoscope
  • 5.2.1.4 Laparoscope
  • 5.2.2 Endoscopic imaging systems
  • 5.2.2.1 Endometrial Ablation Devices
  • 5.2.2.2 Hydrothermal Ablation Devices
  • 5.2.2.3 Radiofrequency Ablation Devices
  • 5.2.2.4 Balloon Ablation Devices
  • 5.2.2.5 Others (Microwave, Laser)
  • 5.2.3 Fluid Management Systems
  • 5.2.4 Female Sterilization/Contraceptive Devices
  • 5.2.4.1 Permanent Birth Control
  • 5.2.4.2 Intra Uterine Devices (IUD)
  • 5.2.4.3 Intravaginal rings
  • 5.2.4.4 Subdermal Contraceptive Implants
• 5.3 Handheld Instruments
  • 5.3.1 Vaginal Speculum
  • 5.3.2 Tenaculum
  • 5.3.3 Curettes
  • 5.3.4 Trocars Market
  • 5.3.5 Biopsy Forceps
  • 5.3.6 Others
• 5.4 Diagnostic Imaging Systems

6 GLOBAL GYNECOLOGICAL DEVICES MARKET, BY END-USER

• 6.1 Overview
• 6.2 Hospital & Clinics
• 6.3 Ambulatory Surgery Centers (ASCs)

7 GLOBAL GYNECOLOGICAL DEVICES MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East and Africa

8 GLOBAL GYNECOLOGICAL DEVICES MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Medtronic plc
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Cooper Surgical, Inc.
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Richard Wolf GmbH
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Hologic, Inc.
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Boston Scientific Corp.
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Stryker Corp.
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Karl Storz GmbH & Co. KG
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Ethicon, Inc. (Johnson & Johnson MedTech)
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Cook Medical
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 Bayer AG
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 Appendix

• 10.1 Related Research